182 related articles for article (PubMed ID: 1730271)
1. Trypanosoma cruzi: predominance of IgG2a in nonspecific humoral response during experimental Chagas' disease.
Spinella S; Liegeard P; Hontebeyrie-Joskowicz M
Exp Parasitol; 1992 Feb; 74(1):46-56. PubMed ID: 1730271
[TBL] [Abstract][Full Text] [Related]
2. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease.
Rowland EC; Mikhail KS; McCormick TS
J Parasitol; 1992 Jun; 78(3):557-61. PubMed ID: 1375959
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies.
el Bouhdidi A; Truyens C; Rivera MT; Bazin H; Carlier Y
Parasite Immunol; 1994 Feb; 16(2):69-76. PubMed ID: 8015857
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi.
Carlier Y; Rivera MT; Truyens C; Goldman M; Lambert P; Flament J; Bauwens D; Vray B
Infect Immun; 1987 Oct; 55(10):2496-501. PubMed ID: 3115899
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease.
Grauert MR; Houdayer M; Hontebeyrie-Joskowciz M
Clin Exp Immunol; 1993 Jul; 93(1):85-92. PubMed ID: 7686828
[TBL] [Abstract][Full Text] [Related]
6. Protected Trypanosoma cruzi infection in rats born to mothers receiving interferon-gamma during gestation is associated with a decreased intramacrophage parasite growth and preferential synthesis of specific IgG2b antibodies.
Didoli GL; Davila HO; Feldman S; di Masso R; Revelli SS; Bottasso OA
Int J Immunopharmacol; 2000 Jan; 22(1):45-55. PubMed ID: 10684988
[TBL] [Abstract][Full Text] [Related]
7. Host genetics and resistance to acute Trypanosoma cruzi infection in mice. I. Antibody isotype profiles.
Powell MR; Wassom DL
Parasite Immunol; 1993 Apr; 15(4):215-21. PubMed ID: 8506117
[TBL] [Abstract][Full Text] [Related]
8. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies.
Ternynck T; Bleux C; Gregoire J; Avrameas S; Kanellopoulos-Langevin C
J Immunol; 1990 Feb; 144(4):1504-11. PubMed ID: 2106000
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ia treatment modulates specific and polyclonal antibody responses in Trypanosoma cruzi-infected mice.
Spinella S; Liegeard P; Guilbert B; Hontebeyrie-Joskowicz M
J Autoimmun; 1989 Dec; 2(6):791-802. PubMed ID: 2515867
[TBL] [Abstract][Full Text] [Related]
10. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi.
Brodskyn CI; Silva AM; Takehara HA; Mota I
Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():343-8. PubMed ID: 2516504
[TBL] [Abstract][Full Text] [Related]
11. Antibody response and antigen recognition in human infection with Trypanosoma cruzi.
Israelski DM; Sadler R; Araujo FG
Am J Trop Med Hyg; 1988 Nov; 39(5):445-55. PubMed ID: 3143270
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi antigen-specific antibody response in immunized mice during acute and chronic infection.
Mikhail KS; Rowland EC
J Parasitol; 1990 Oct; 76(5):690-7. PubMed ID: 2120413
[TBL] [Abstract][Full Text] [Related]
13. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease.
Solana ME; Katzin AM; Umezawa ES; Miatello CS
J Clin Microbiol; 1995 Jun; 33(6):1456-60. PubMed ID: 7650167
[TBL] [Abstract][Full Text] [Related]
14. Immunoparasitological studies of Trypanosoma cruzi low virulence clones from Panama: humoral immune responses and antigenic cross-reactions with Trypanosoma rangeli in experimentally infected mice.
Saldaña A; Sousa OE; Orn A
Scand J Immunol; 1995 Dec; 42(6):644-50. PubMed ID: 8552988
[TBL] [Abstract][Full Text] [Related]
15. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease.
Morgan J; Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Colley DG; Powell MR
Am J Trop Med Hyg; 1996 Oct; 55(4):355-9. PubMed ID: 8916788
[TBL] [Abstract][Full Text] [Related]
16. Most B cells in acute Trypanosoma cruzi infection lack parasite specificity.
Minoprio P; Burlen O; Pereira P; Guilbert B; Andrade L; Hontebeyrie-Joskowicz M; Coutinho A
Scand J Immunol; 1988 Nov; 28(5):553-61. PubMed ID: 2463663
[TBL] [Abstract][Full Text] [Related]
17. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.
Bermejo DA; Amezcua-Vesely MC; Montes CL; Merino MC; Gehrau RC; Cejas H; Acosta-Rodríguez EV; Gruppi A
PLoS Negl Trop Dis; 2010 May; 4(5):e679. PubMed ID: 20454564
[TBL] [Abstract][Full Text] [Related]
18. Antibody isotypes profiles against Trypanosoma cruzi acidic antigens in two Amerindian populations from a Chagas' disease endemic area.
Motran CC; Serra HM; Gea SE; Vullo CM; Vottero-Cima E
Acta Trop; 1994 Nov; 58(2):105-14. PubMed ID: 7887336
[TBL] [Abstract][Full Text] [Related]
19. Analysis of anti-Trypanosoma cruzi antibody isotype specificities by western blot in sera from patients with different forms of Chagas' disease.
Morgan J; Colley DG; Pinto Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Powell MR
J Parasitol; 1998 Jun; 84(3):641-3. PubMed ID: 9645878
[TBL] [Abstract][Full Text] [Related]
20. Non-antibody-mediated control of parasitemia in acute experimental Chagas' disease.
Trischmann TM
J Immunol; 1983 Apr; 130(4):1953-7. PubMed ID: 6403614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
